From: Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging
HCM patients (N = 50)
Control group (N = 40)
p value
LVEDV(ml)
70.12 ± 13.91
85.59 ± 14.94
< 0.001
LVESV (ml)
31.09 ± 6.02
29.46 ± 5.47
0.187
LVSV (ml)
39.94 ± 10.67
56.25 ± 11.68
LVEF(%)
57.17 ± 4.15
65.13 ± 2.95